Kenneth Ian Weissman Sells 8,000 Shares of IMAX (NYSE:IMAX) Stock

IMAX Corporation (NYSE:IMAX) insider Kenneth Ian Weissman sold 8,000 shares of the firm’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $54.54, for a total value of $436,320.00. Following the transaction, the insider owned 28,205 shares in the company, valued at approximately $1,538,300.70. This trade represents a 22.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

IMAX Price Performance

IMAX opened at $51.92 on Friday. IMAX Corporation has a 1 year low of $28.14 and a 1 year high of $55.57. The company has a market capitalization of $2.85 billion, a price-to-earnings ratio of 72.11, a P/E/G ratio of 1.69 and a beta of 0.38. The firm’s fifty day moving average price is $45.43 and its two-hundred day moving average price is $40.67.

IMAX (NYSE:IMAX) last released its quarterly earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.13. IMAX had a net margin of 9.84% and a return on equity of 15.47%. The company had revenue of $102.84 million for the quarter, compared to analyst estimates of $96.09 million. During the same period last year, the firm earned $0.26 earnings per share. The firm’s revenue was up 12.2% on a year-over-year basis. As a group, equities analysts anticipate that IMAX Corporation will post 1.49 EPS for the current year.

Analyst Upgrades and Downgrades

IMAX has been the topic of a number of research analyst reports. The Goldman Sachs Group restated a “neutral” rating and issued a $42.00 target price on shares of IMAX in a research note on Thursday, July 23rd. Rosenblatt Securities reiterated a “buy” rating and set a $60.00 price target on shares of IMAX in a report on Wednesday, August 19th. Weiss Ratings raised IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, July 16th. Barrington Research upped their price objective on IMAX from $46.00 to $50.00 and gave the company an “outperform” rating in a research note on Friday, July 24th. Finally, JPMorgan Chase & Co. upped their price objective on IMAX from $47.00 to $50.00 and gave the company an “overweight” rating in a research note on Friday, July 24th. Ten equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, IMAX presently has a consensus rating of “Moderate Buy” and a consensus price target of $52.36.

Key Stories Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: IMAX continues to secure high-profile film partnerships. Netflix’s upcoming Cliff Booth movie is set for an IMAX release, while Godzilla Minus Zero is expected to become the first Japanese IMAX film, supporting the company’s pipeline and potential box-office revenue. Netflix Cliff Booth IMAX article Godzilla Minus Zero IMAX article
• Positive Sentiment: Individual theaters are continuing to invest in the format. A downtown theater upgraded to laser projection for its 30th anniversary, and Mann Theatres plans to add an IMAX auditorium in Plymouth. These projects can expand IMAX’s installation base and future licensing and maintenance opportunities. Downtown IMAX laser upgrade article Mann Theatres Plymouth IMAX article
• Positive Sentiment: Reports of record ticket sales for The Odyssey, along with a limited two-day IMAX run for the Queen concert film, point to continued consumer interest in premium screenings. The Odyssey IMAX projector article Queen Budapest IMAX article
• Neutral Sentiment: An article explaining the difference between genuine IMAX and lower-specification “LieMAX” screens may help educate consumers, but it also highlights potential confusion over the consistency of the IMAX experience across venues. IMAX versus LieMAX article
• Negative Sentiment: CFO Natasha Fernandes sold 20,000 shares for approximately $1.09 million, reducing her holdings by nearly 36%. Insider Kenneth Ian Weissman separately sold 8,000 shares worth about $436,000, cutting his position by roughly 22%. The sales may pressure sentiment, particularly after IMAX’s strong rally.
• Negative Sentiment: Valuation remains a risk: IMAX trades at roughly 72–73 times earnings despite the stock being near its 52-week high. That leaves shares vulnerable to profit-taking if upcoming releases or theater expansion fail to meet elevated expectations. The company’s latest reported quarter was strong, with revenue up 12.2% year over year and EPS exceeding estimates, but analysts forecast only about $1.49 in full-year EPS.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of IMAX. AQR Capital Management LLC increased its stake in shares of IMAX by 47.9% during the 1st quarter. AQR Capital Management LLC now owns 56,348 shares of the company’s stock worth $1,485,000 after purchasing an additional 18,238 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in IMAX by 4.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,486 shares of the company’s stock valued at $672,000 after purchasing an additional 1,091 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in IMAX by 7.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 159,714 shares of the company’s stock valued at $4,208,000 after purchasing an additional 11,736 shares during the period. Creative Planning increased its position in IMAX by 84.1% in the second quarter. Creative Planning now owns 16,081 shares of the company’s stock worth $450,000 after buying an additional 7,344 shares during the last quarter. Finally, Norges Bank purchased a new stake in IMAX in the second quarter worth $709,000. 93.51% of the stock is owned by institutional investors.

IMAX Company Profile

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.